A pioneering method of delivering research – popularised during the height of the COVID-19 pandemic – is being leveraged for the benefit of Greater Manchester residents.
Patients at Manchester University NHS Foundation Trust (MFT) are benefitting from more than 40 combined years of healthcare experience provided by one family of nurses.
The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.
The MFT-hosted NIHR Manchester Clinical Research Facility (MCRF) has received a £15.5 million award, widening opportunities for people across Greater Manchester to participate in research.
In her blog Gabby Addison shares her student nurse experiences at the NIHR Manchester Clinical Research Facility, and how she is proud to be back as a Clinical Research Nurse.